Coding & Medicare
Time for a financial deep dive
A review of your practice’s financial metrics can help you spot problems in your billing system.
Documenting IVI: Avoiding audit traps
Documentation of intravitreal anti-VEGF injections is key as Medicare puts them under the microscope.
EO: If you do it, you should bill it
Extended ophthalmoscopy is a charge retina specialists commonly miss. Here’s how to bill for it.
Is your ‘new normal’ compliant?
A compliance plan can be more than meeting a mandate. It can improve your operations. Here’s a nuts-and-bolts approach.
Clearing up E/M ‘clarifications’
The AMA issued new evaluation and management guidelines that can be hard to appreciate.
New E/M codes are here. Now what?
A strategy for meeting the new requirements for Evaluation and Management codes.
The Stark (law) truth
A look at how the latest revisions to self-referral regulations meant to facilitate collaborative care may impact your practice.
Why was your test payment cut?
Making sense of the Multiple Procedure Payment Reduction.
Untangling the web of ‘bundles’
The National Correct Coding Initiative prohibits selected coding bundles, so if you must bundle, just submit one code—the higher one.
Documentation still counts
In the COVID-19 pandemic, one old rule still applies: If you didn’t write it down, you didn’t do it.
New day for extended ophthalmoscopy
New rules and codes apply starting this year. The requirements are tighter and the reimbursements lower.
Coding for surgery in the postop period
How to use modifiers 58, 78 and 79 for a planned or unplanned trip back to the OR.
Is laser for vitreous floaters covered?
Answers to one of the most common questions our coding expert gets.
2019 updates, changes and trends
Some of the coding changes are minor, others not so. Here’s a rundown.
Coding and Reimbursement Updates
Changes in 2016 amount to a sharp reduction in physician reimbursements.
Making Sense of PQRS and VBPM
Knowing Medicare’s key measures can help you avoid penalties. Part 1 of 2.
Genetic Tests: A Coverage Challenge
AAO advises restraint with genetic testing; payers go slow.
OCT and FP: Why can’t I bill both?
New guidance from CMS describes why and the few times when you can.
Current Issue
Continuing Medical Education
Additional Publications
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
Eyepoint Yutiq: A Discussion Among Experts on the Treatment of Uveitis Affecting the Posterior Segment
